National Nonprofit SoldierStrong Announces 2024 Recipients of Annual Commitment to Service Award
LTG (Ret) Patricia “Patty” D. Horoho LTG (Ret) Patricia “Patty” D. Horoho Bobby Rahal Automotive Group Bobby Rahal Automotive Group...
Month: February 2025
SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX) today announced that...
PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI
Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin...
Dror Ortho-Design Partners with Aran R&D to Advance Production
Aran R&D 3D Printing Division Founded in 1982, Aran is a pioneering Israeli product design and development firm and an...
Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June 2024ATLANTA, Feb. 04, 2025...
Surplus Solutions Expands Global Offerings with Refurbished Analytical and Medical Equipment, Supported by New Brand and Website Launch
Surplus Solutions Refurbished Equipment Surplus Solutions expands globally with Certified Surplus™ refurbished lab & medical equipment, a new brand, and...
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will...
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC
FORT MILL, S.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device...
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04,...
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
MIAMI, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Allogene Therapeutics Announces Participation in February Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
TOMI Environmental Solutions Expands Deployment of SteraMist for California Wildfire Recovery
Company’s Decontamination Technology Addresses Airborne and Surface Contaminants in Fire-Damaged StructuresFREDERICK, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental...
Coloplast Finance B.V. – Interim Financial Report, Q1 2024/25
2024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an...
Blue Cross Blue Shield of Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine
Nearly three million members of the largest health insurance plan in Massachusetts are now eligible for reimbursement when prescribed with...
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
– Submission of Investigational New Drug Application (IND) to US FDA expected in 2025 – NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE)...
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future
“Highlights 2024 Collaborative Partnerships and Product Development Designed to Spur Growth in 2025 and Beyond”NAPLES, Fla., Feb. 04, 2025 (GLOBE...
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
The study met its primary endpoint with no procedure or device related serious adverse events reportedRUTHERFORD, N.J., Feb. 04, 2025...
Safe Supply’s Proprietary Test Kits to Assist with Fighting the Fentanyl Problem and Support in Securing Borders
Recent policy initiatives demonstrate the importance of Safe Supply's products to provide leading tools and solutionsToronto, Ontario--(Newsfile Corp. - February...